Here are five things to know:
1. Quell is a wearable pain relief device that uses non-invasive neurostimulation technology to reduce chronic pain.
2. Ideal wearers of the device include those with diabetic nerve pain, low back and leg pain, fibromyalgia and osteoarthritis.
3. The FDA cleared the device for treatment of chronic pain without a prescription.
4. In a clinical study, 81 percent of participants said the app improved their pain management, and 67 percent said they reduced pain medications when wearing the app.
5. The Android app provides users with a therapy dashboard, therapy and sleep tracking.
More articles on devices:
EOS imaging acquires rights to new scoliosis prognosis technology: 5 key notes
NovaBone Products receives allowance notice for 2nd collagen-related patent: 4 observations
Legacy Salmon Creek offers MAKOplasty technology — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
